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Abstract 
This study has determined the concentrations of Total Cholesterol (TC), High Density Lipoprotein (HDL), Low  
Density Lipoprotein (LDL), Triacylglyceride (TG),  Very Low Density Lipoprotein (VLDL),  Mineral Elements 
and some Electrolytes. Subjects used for this study were made up of 180 women with preeclampsia and 80 
normotensive pregnant women, who attended antenatal and postnatal clinics of the Ekiti State University 
Teaching Hospital, Ado-Ekiti and Federal Medical center, Ido-Ekiti, Ekiti State, Nigeria. In addition, 80 control 
volunteers were also involved in this study. The control participants comprise of 40 normotensive and 40 
hypertensive non-pregnant women randomly selected. They were also non-users of contraceptives therapy. 
Anthropometric measurements including age, parity, blood pressure, height and weight were recorded for the 
subjects.  Plasma concentrations of each of the biomarkers were determined using test kits, based on established 
methods, in the subjects at 1st trimester , 2nd trimester and  3-6 days post-partum. The results in the hypertensive 
pregnant subjects were compared statistically (P<0.05), with the normotensive pregnant subjects. TC, LDLC, 
VLDLC and TG increase significantly in PIH subjects, but HDL showed significant decrease in the preeclampsia 
subjects ,as the pregnancy progresses to the 3rd trimester. At post –partum the lipid profile becomes normal again 
in preeclampsia. Subjects with preeclampsia showed more significant decrease in the levels of Ca, Mg, Na, and P 
elements.   This research work pointed out clearly that, Plasma lipids and some mineral elements are implicated 
in Pregnancy Induced Hypertension. They may be likely etiological factors in the disease, and may also serve as 
indicators for early detection.  
Keywords: Preeclampsia, Total Cholesterol (TC), High Density Lipoprotein (HDL), Low  Density Lipoprotein 
(LDL), Triacylglyceride (TG),  Very Low Density Lipoprotein (VLDL), Mineral elements. 
 
INTRODUCTION 
Pregnancy refers to the period from conception to the expulsion of the foetus. This period constitutes in a 
woman's life a special condition that affects various physiologic and endocrinology systems as a result of 
adaptation of the mother to accommodate and support the foetus before and after parturition (Davey, 1988). 
Pregnancy is a natural state that sets up great changes throughout the whole body. Throughout gestation, the 
physiological changes occur in pregnant women and most of these changes subside quickly after delivery 
(Guice-Booth, 2005). Pregnancy can be complicated by at least two distinct types of hypertension. The first one 
is chronic hypertension, which is usually characterized by blood pressure greater than 140/90mmHg. The second 
type is Pregnancy Induced Hypertension (PIH), and also known as pre-eclampsia. Preeclampsia is a 
complication that results to the development of hypertension after about twenty (20) weeks of gestation in a 
woman who had previously been normotensive (with no pre-existing renal disease). A patient with preeclampsia 
will begin her pregnancy with a normal blood pressure but it will rise sometime in the third trimester in typical 
cases, but earlier in severe cases. A rise in the blood pressure by 30/20mmHg (e.g. from 90/50mmHg to 
120/70rnmHg) over the course of the pregnancy is a diagnostic criterion, even though the final pressure may 
seem normal (Sibai et al., 2007).  
Preeclampsia is one of the major causes of maternal death throughout the world (Chesley, 1987). It has 
been suggested that one or more of the protective mechanisms are either deficient or fails to functions properly 
or even gets out of control. 
The exact cause of preeclampsia is unknown, and currently there is no sure way to prevent the 
hypertension (Oyeyemi and Asaolu, 2015). 
Lipids are molecular organic compounds composed largely of carbon and hydrogen that are essential 
for cell growth. Lipids are non soluble in water and combine with carbohydrates and proteins to form the 
majority of all plants and animal cells. Lipids are more commonly synonymous with the word ‘fats’ when 
speaking in terms of personal health and though all fats are not all lipids. Plasma lipids include Cholesterol  and 
Triacylglyceride. Cholesterol is a naturally occurring substance in the body and its composed of lipids. It’s a 
waxy substance produced by the liver and found in certain foods and needed to make vitamin D and some 
hormone, build cell walls and create bile salts that helps to digest fats. They are found in foods from animal 
source while vegetables, fruits and grains contain none. The liver produces about 1000mg of cholesterols per day 
and an individual probably consumes about 150 to 250mg in the foods eaten. Cholesterol is separated into two 
types, such as high density lipoprotein (HDL) and low density lipoprotein (LDL). In a lipid test, the lipoproteins 
are separated so that the levels of each can be measured. Lipid tests are part of preventive routines cases, as they 
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help determine whether there are significant risks of atherosclerosis, a hardening of the arteries that interferes 
with or interrupts blood flow. The lipoprotein levels are measured and dietary changes are usually in order when 
the total cholesterol approaches or rise above 200mg per decimeter in the blood (Schaefer et al., 1995) 
Cholesterol is transported through the blood stream in the form of large chylomicrons or lipoprotein, 
LDL transport cholesterol to peripheral tissues and regulates de novo cholesterol synthesis at these sites. HDL 
picks up cholesterol released in to the plasma from dying cells and from membranes undergoing turnovers. An 
acyl transferase in HDL esterifies these cholesterol which are then returned by HDL in the liver or to the tissues 
that uses cholesterol to synthesize steroid hormones (Ostos et al; 2002). LDL clogs the blood vessels keeping 
blood from flowing through the body the way it should. When LDL levels are high, cholesterol is deposited on 
the walls of the arteries and forms a hard substance called plague. Over time, the plague causes the arteries to 
become narrower, decreasing blood flow and causing a condition called atherosclerosis or hardening of the 
arteries. This affects the coronary arteries that supply blood to the muscles of the heart; it is called coronary 
artery diseases, which puts a person at risk of having heart attack. When atherosclerosis affects the blood levels 
that supply the brain blood, the condition is called cerebral vascular disease which puts the person at risk of 
having a stroke. It may also block flow to other vital organs including the kidney and intestines (Ostos et al; 
2002). 
Triglycerides are also a form of fats in the blood stream. People with high triglycerides levels often 
have high total cholesterol, a high cholesterol LDL, a low cholesterol HDL levels. Many individuals with heart 
disease also have high triglyceride levels. Several clinical studies have shown that people with above normal 
triglyceride levels (greater than or equal to 200mg/dl) have an increased risk of heart disease. Also people with 
diabetes or who are obese are also likely to have high triglycerides (Gotto, 1998). 
Mineral elements such as Na, K, P, Mg, Fe and so on, are important part of the body fluids which 
perform great roles in the body system. Tests that measure the concentrations of mineral elements and  
electrolytes are needed for both the diagnosis and management of renal endocrine, acid-base, water balance and 
many other conditions. Their importance lies in part with the serious consequences that follow from the 
relatively small changes that diseases or abnormal conditions may cause. For example, the reference range of 
potassium is 3.6–5.0mmol/L.  Potassium is first used as STAT (needed immediately) test because values below 
3.0mmol/L are associated with arrhythmia (irregular heartbeat), tachycardia (rapid heartbeat) and cardiac arrest 
and above 6.0mmol/L are associated with bradycardia (slow heart beat) and heart failure. Sodium measurement 
are also very useful in differentiating the cause of an abnormal potassium results, conditions such as the overuse 
of diuretics (drugs that promote lower blood pressure) often result in low levels of sodium and potassium. On the 
other hand, cushing’s disease and Addison’s disease drive the sodium and potassium in opposing directions 
(Henry, 2001). 
 
MATERIALS AND METHODS  
Subjects 
Subjects used for this study were made up of 180 hypertensive pregnant women and 80 normotensive pregnant 
women, who attended antenatal and postnatal clinics of the Ekiti State University Teaching Hospital, Ado-Ekiti 
and Federal Medical center, Ido-Ekiti, Ekiti State, Nigeria. In addition, 80 control volunteers were also involved 
in this study. The control participants comprise of both normotensive and hypertensive non-pregnant women 
randomly selected. They were also non-users of contraceptives therapy. 
 
Recruitments of Subjects 
The subjects used for this work were divided into four (4) groups. 
 
Group 1 
In this group, the subjects were 180 hypertensive pregnant women (HPW) with symptoms of Pregnancy Induced 
hypertension (pre-eclampsia), brought into Ekiti State Teaching Hospital, Ado – Ekiti and Federal Medical 
Centre, Ido –Ekiti for management and treatment. Eighty (80) of the subjects were in their 2nd trimesters while 
40 were in their 3rd trimesters respectively. They were monitored up to three to six days after delivery. 
 
Group 2 
Subjects in this group were 80 in number. They were randomly selected and were normotensive pregnant women 
(NPW) in their 2nd and 3rd trimesters of pregnancy. They were attending the antenatal clinics of Ekiti State 
Teaching Hospital, Ado – Ekiti and Federal Medical Centre, Ido –Ekiti. They were also mornitored to three to 
six days after delivery. They serve as controls for group 1. 
 
Group 3 
This group was made up of 40 hypertensive non pregnant women (HNPW) and non- users of contraceptive 
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therapy  randomly selected. 
 
Group 4  
This group also consisted of 40 normotensive non-pregnant women (NNPW) and non- users of contraceptive 
therapy randomly selected. The subjects here serve as control to group 3.   
 
Selection of subjects 
The selection of Hypertensive subjects in this study was made by screening patients admitted from the antenatal 
and post natal wards of of Ekiti State Teaching Hospital, Ado – Ekiti and Federal Medical Centre, Ido –Ekiti. 
They were all having a blood pressure greater than 140/90 mmHg at the time of sampling. The blood pressure 
was measured by means of sphygmomanometer. It was also noted that none of the hypertensive pregnant women 
had any evidence of chronic renal disease or any other medical Obstetrics and Gyneacology complications apart 
from hypertension. However some of the subjects were having oedema and proteinuria. 
 In the case of the normotensive pregnant women,  they were all healthy, and none of them gave any 
history of hypertension or other diseases and they were non- contraceptive users. 
 
Collections of samples 
All the subjects in each group while resting and supine had 10ml of their venous non fasting blood samples 
collected into lithium heparinised anticoagulant bottles. The blood was immediately centrifuged at 4,000 
revolutions per minute (rpm) for 15minutes, and separated to obtain the plasma. The samples were then analyzed 
to obtain the concentrations of all the desired parameters in this study. 
 
Biochemical assay 
Plasma Total cholesterol in all the samples collected from all the subjects was analyzed by the cholesterol 
CHOD-PAP method which is an enzymatic end point method ( Trinder, 1988). HDL in the sample was separated 
by precipitation through the procedure adopted by Lopes- Virella (1977).LDL-Cholesterol concentration in the 
sample was determined using the relationship described by Frederickson-Frieldwald et al., (1972).The 
concentration of VLDL-cholesterol in the sample was analysed by a simple relationship described by 
Frederickson-Frieldwald et al., (1972).GPO-PAP method of Randox diagnostic kit (Trinder, 1988) was used to 
determine Triacylglerol. 
Estimation of sodium and potassium were analyzed  using flame emission photometry the method as 
described by AOAC 1990. Plasma levels of the elements (Zn, Fe, Ca, Mg, Mn, Pb, P, Cd, Cu) were determined 
using atomic absorption spectophotometry as described by AOAC 1990. 
 
Statistical Analysis 
The data collected was analyzed using one –way Analysis of variance (ANOVA) and Duncan multiple range test 
to compare the data obtained from the experiment to those of the control . 
 
RESULTS AND DISCUSSION 
Tables 1a, 1b and 1c represents the lipid profile results.TC, LDLC, VLDLC and TG increase significantly in PIH 
subjects. HDL on the other hand showed significant decrease in the PIH  subjects as the pregnancy progresses to 
the 3rd trimester. At post-partum, TC, LDLC, VLDLC, and TG significantly decrease , while HDL increases 
significantly in PIH subjects as compared with the normotensive pregnant group. 
TABLE 1a Plasma Lipid Profile, and Total Cholesterol concentrations (mmol/L), in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C], and 
hypertensive pregnant women [D], at 2nd trimester. 
PARAMETERS 
 
       A         B          C              D    Ls 
TC 3.71±o.62a 4.32±0.44c 4.00±0.43a 5.99±0.34b P<0.001 
HDLC 2.53±0.42a 1.99±0.30c 2.40±0.31a 1.08±0.40b P<0.001 
LDLC 0.84±0.50a 1.60±0.50b 0.85±0.40a 1.68±0.42b P<0.001 
VLDLC 0.26±0.18a 0.42±0.20c 0.30±0.15a 0.71±0.30b P<0.001 
TG 0.58±0.30a 0.90±0.22b 0.60±0.30a 1.30±0.50b P<0.001 
SBP (mmHg) 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b P<0.05 
DBP (mmHg) 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different. 
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TABLE 1b:  Plasma Lipid Profile, and Total Cholesterol concentrations (mmol/L), in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C], and 
hypertensive pregnant women [D], at 3rd trimester. 
PARAMETERS 
 
        A         B        C          D        Ls 
TC 3.71±0.62a 4.32±0.44c 4.00±0.50a 6.12±0.30b P<0.001 
HDLC 2.53±0.42a 1.99±0.30c 2.52±0.30a 0.88±0.40b P<0.001 
LDLC 0.84±0.50a 1.60±0.50c 1.35±0.45a 2.61±0.30b P<0.001 
VLDLC 0.26±0.18a 0.52±0.20c 0.30±0.04a 0.82±0.32b P<0.001 
TG 0.58±0.30a 0.90±0.22c 0.63±0.10a 1.51±0.45b P<0.001 
SBP (mmHg) 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b P<0.05 
DBP (mmHg) 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different.  
 
TABLE 1c: Plasma Lipid Profile, and Total Cholesterol concentrations (mmol/L), in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C], and 
hypertensive pregnant women [D], at 3-6 days post-partum. 
PARAMETERS          A         B         C          D        Ls 
TC 3.71±o.62a 4.32±0.44c 4.03±0.51a 5.71±0.30b P<0.001 
HDLC 2.53±0.42a 1.99±0.30c 2.51±0.30a 1.72±0.40b P<0.001 
LDLC 0.84±0.50a 1.60±0.50b 1.23±0.40a 1.61±0.40b P<0.001 
VLDLC 0.26±0.18a 0.42±0.20c 0.27±0.20a 0.72±0.33b P<0.001 
TG 0.58±0.30a 0.90±0.22c 0.65±0.31a 1.29±0.32b P<0.001 
SBP (mmHg) 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b P<0.05 
DBP (mmHg) 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different. 
Tables 2a, 2b and 2c reveal the results or the elements and electrolytes determined in this study. 
Subjects with PIH showed more significant decrease in the levels of Ca, Mg, Na, and P. However these elements 
showed significant increase at post–partum in PIH group. Other elements and electrolytes; K, Cl, HCO3, Fe and 
Zn, did not show any significant change in their levels in both normotensive and PIH patients as compared with 
the control subjects. 
TABLE 2a: Plasma concentrations of elements, electrolytes, urea and creatinine in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C] and 
hypertensive pregnant women [D] at  2nd trimester. 
PARAMETERS    A      B       C        D                  Ls 
Na (mmol/L) 141±2.0a 140±2.0a 136±2.3b 130±2.4c  P<0.005 
K   (mmol/L) 4.2±1.0a 4.3±1.1a 4.2±1.2a 3.9±1.2a  P<0.005 
Ca (mmol/L) 4.8±0.2a 4.6±0.2a 4.2±0.3b 3.4±0.2c  P<0.005 
Mg (mmol/L) 0.74±0.1a 0.71±0.1a 0.62±0.1b 0.50±0.2c  P<0.001 
Fe (mmol/L) 0.031±0.1a 0.029±0.10a 0.028±0.12a 0.028±0.13a  P<0.001 
Cl (mmol/L) 102±2.3a 103±2.5a 101±2.4a 100±2.3a  P<0.005 
HCO3 (mmol/L) 24.1±2.2a 24.4±2.1a 24.1±2.0a 23.3±2.2a  P<0.005 
P (mmol/L) 0.9±0.13a 0.87±0.12a 0.72±0.12b 0.51±0.14c  P<0.005 
Zn (mmol/L) 0.011±0.004a 0.010±0.003a 0.010±0.003a 0.009±0.002a  P<0.001 
SBP(mmHg) 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b  P<0.05 
DBP(mmHg) 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b  P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different. 
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TABLE 2b: Plasma concentrations of elements, electrolytes, urea and creatinine in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C] and 
hypertensive pregnant women [D] at  3rd  trimester. 
PARAMETERS A            B        C        D Ls 
Na(mmol/L) 141±2.0a 140±2.0a 125.1±2.3b 110.5±2.5c P<0.005 
K(mmol/L) 4.2±1.0a 4.3±1.1a 3.74±1.2a 3.77±1.2a P<0.005 
Ca(mmol/L) 4.8±0.2a 4.6±0.2a 4.29±0.3b 3.15±0.3c P<0.005 
Mg(mmol/L) 0.74±0.1a 0.71±0.1a 0.61±0.1b 0.41±0.2c P<0.001 
Fe(mmol/L) 0.031±0.01a 0.029±0.010a 0.025±0.012a 0.23±0.013a P<0.001 
Cl(mmol/L) 102±2.3a 103±2.5a 97.9±2.4a 96.5±2.3a P<0.005 
HCO3(mmol/L) 24.1±2.2a 24.4±2.1a 23.0±2.0a 22.5±2.2a P<0.005 
P(mmol/L) 0.9±0.013a 0.87±0.012a 0.69±0.012b 0.45±0.014c P<0.005 
Zn(mmol/L) 0.011±0.004a 0.010±0.003a 0.09±0.003a 0.76±0.002a P<0.001 
SBP mmHg 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b P<0.05 
DBP mmHg 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different. 
TABLE 4.4c: Plasma concentrations of elements, electrolytes, urea and creatinine in normotensive non 
pregnant women [A], hypertensive non pregnant women [B], normotensive pregnant women [C] and 
hypertensive pregnant women [D] at  3-6 days post-partum. 
PARAMETERS A       B        C    D             Ls 
Na(mmol/L) 141±2.0a 140±2.0a 130.3±2.2b 115.9±2.4c P<0.005 
K(mmol/L) 4.2±1.0a 4.3±1.1a 3.75±1.2a 3.89±1.2a P<0.005 
Ca(mmol/L) 4.8±0.2a 4.6±0.2a 4.40±0.3b 3.45±0.3c P<0.005 
Mg(mmol/L) 0.74±0.1a 0.71±0.1a 0.71±0.1b 0.45±0.1c P<0.001 
Fe(mmol/L) 0.031±0.011a 0.029±0.010a 0.027±0.001a 0.23±0.001a P<0.001 
Cl(mmol/L) 102±2.3a 103±2.5a 97.9±1.3a 96.4±2.4a P<0.005 
HCO3(mmol/L) 24.1±2.2a 24.4±2.1a 23.1±2.4a 22.4±2.3a P<0.005 
P(mmol/L) 0.9±0.13a 0.87±0.12a 0.74±0.21b 0.69±0.14c P<0.005 
Zn(mmol/L) 0.011±0.004a 0.010±0.03a 0.09±0.013a 0.89±0.3a P<0.001 
SBP mmHg 98.7±10.42a 161±13.45b 104±4.91a 151±4.24b P<0.05 
DBP mmHg 67.15±10.18a 107±12.45b 66±3.58a 96±7.89b P<0.05 
Results are presented as means ± standard error of mean.  Values with different superscript are 
significantly different.  
The present study showed clearly plasma  lipid elevations in PIH group and the results obtained from 
the present study showed significantly higher levels (p< 0.001) of plasma TC, TG, LDLC, and VLDLC and 
significantly lower levels of HDLC levels in hypertensive pregnant women compared to the normotensive 
pregnant women (Tables 1a, and 1b) This agrees with the report of Franz and Wendler, (1992). The TC level in 
PIH cases was found to be higher  than the  normotensive pregnant women. These findings are in agreement with 
the studies reported by Sattar et al. (1997). Also the result obtained in the present study, which shows the plasma 
TG levels of hypertensive cases to be  higher than the controls, tallies with what has been reported in previous 
studies by Das and Ischei (1996). Also the mean VLDLC in PIH cases rose significantly compared to the 
controls, which may be due to hyper triglyceridemia leading to enhanced entry of VLDL that carries endogenous 
triglyceride into circulation. The increased VLDLC levels in the hypertensive pregnant women in this present 
study correlates with the findings of other researchers (Sattar et al, 1997). 
Plasma LDLC levels in this study which are significantly higher in PIH corroborated with the findings 
of other studies (Hubel et al., 1989 and Sattar et al., 1997). In addition, the HDLC levels in PIH cases are low as 
compared with the controls. These findings are also similar to the studies done by Kaaja  et al. (1995). It is 
suggested that the low levels of HDLC in hypertensive pregnancy may not only be because of hypo-
oestrogenaemia but, may also be due to insulin resistance which is enhanced by low level of Ostrogen (Kaaja et 
al., 1995). Therefore it is evident that dyslipidemia was found in PIH cases. The elevated TC, TGL, VLDLC, 
and LDLC levels and reduced HDLC levels may be due to exaggerated insulin resistance and low estrogen levels 
which may contribute to the pathogenesis. 
Table 1c reveals the result for all the plasma lipids at 3-6 days post partum. It was found that TC, TG, 
VLDLC, and LDLC levels significantly  decreases from the values obtained in the 3rd trimester in PIH  subjects 
(P<0.001). In normotensive pregnancy, the values also reduce insignificantly from what was observed in the 3rd 
trimester. This result correlates with the work of Das and Isichei (1996) . The result of this study on the plasma 
lipids suggest that PIH subjects may have as much or even more of cardiovascular risk index as a result of the 
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increase in lipids. 
Tables 2a and 2b show the results of the elements and electrolytes determined in both normotensive 
pregnancy and PIH patients during 2nd and 3rd trimesters respectively. The levels of these elements; Ca, Mg, Na, 
and P were seen to decrease insignificantly (P<0.05) in  normotensive, but significantly in hypertensive 
pregnancy as compared with the non-pregnant subjects. The result of the hypertensive non pregnant group has no 
significant change from the normotensive non pregnant group. However a significant decrease was seen in the 
levels of the elements during  the 3rd trimester.  Patients with PIH showed more significant decrease compared 
with those with normotensive pregnancy (P<0.05). Renal excretion of calcium and phosphate increases during 
pregnancy (Mozdzien et al, 1995). Excretion usually increases during each trimester, with maximum levels 
reached during the third trimester. It is reported that a daily supplement of 2000 mg calcium had significant 
results in lowering the incidence of toxemia (Cong et al, 1995). There was a significant decrease in the plasma 
magnesium levels in the normal pregnancy cases as compared to those in the non- pregnant controls, and Mg 
significantly decreased more in PIH. Our findings are consistent with the reports of other researchers, (Seydoux 
et al, 1992). Magnesium affects the cardiac and smooth muscle cells by altering the transport of calcium and its 
binding to the membrane and organ cells. Magnesium acts peripherally to produce peripheral vasodilatation and 
a fall in blood pressure. Thus, low levels of magnesium predispose to an increase in the arterial 
pressure(Standley et al, 1997). Magnesium is known to increase the prostacycline release from the endothelial 
cells of the blood vessels, which acts as a potent vasodilator. In addition, magnesium depletion increases the 
vasoconstrictor effect of angiotensin II and nor-adrenaline. 
Plasma sodium levels was also found  to be significantly decreased in the PIH cases as compared to that 
in the non-pregnant controls and in the normotensive pregnant women. The findings are in accordance with those 
reported by other authors, Clarke (1997). In PIH, sodium transport is altered across the cell membrane and this 
leads to the accumulation of sodium in the extravascular spaces and a decrease in the plasma sodium levels.  
Other element and electrolytes (K, Cl, HCO3, Fe and Zn) as seen from both Tables 2a and 2b did not 
show any significant in their levels in both normotensive and PIH patients as compared with the control subjects. 
This result  in agreement with the work of Indumati et al 2011, suggests that these electrolytes may not really be 
implicated in the etiology of PIH. 
The plasma levels of Ca, Mg, Na and P that significantly decreased in 2nd and 3rd  trimesters began to 
show significant increase (P<0.05) at post-partum in  PIH patients. For normotensive pregnant patients, an 
insignificant increase was seen (P>0.05). The significant increase at post-partum in these electrolytes further 
suggests their implication in PIH. This result agrees with the work of   Hurd et al.,(2002).      
 
CONCLUSION              
In conclusion, the result obtained in this study on the Plasma lipids suggests dyslipidemia in preeclampsia cases. 
The abnormal lipid metabolism particularly high triglycerides, high TC, high LDLC , and low HDLC levels may 
favor formation of atheromatous plaques that lead to cardiovascular disease. Therefore, it is recommended that 
blood lipid concentrations should be evaluated in pregnant women and women with PIH during antenatal care 
which may provide information to clinician about high risk pregnancies and helpful in prevention of 
complications. Further diets which can raise HDLC levels are recommended to preeclampsia patients. 
Furthermore, elements such as Ca, Na, Mg, and P  have been implicated in PIH as seen in this study. They all 
significantly decreased in preeclampsia. Moreover, from the results in this study, though calcium and magnesium 
deficiencies cannot be pin pointed as the sole factors for the etiology of preeclampsia, but their relationship with 
preeclampsia cannot be denied. Both magnesium and sodium are known to decrease the intracellular calcium by 
different mechanisms, thus leading to smooth muscle contraction and an elevation in blood pressure.The 
recommended daily allowance of calcium for a pregnant woman is 1200 mg. Thus, along with a dietary 
restriction of sodium, a dietary supplementation of calcium and magnesium in the form of milk, cheese, soybean 
products, leafy vegetables, etc. during pregnancy, could result in a reduction in the incidence of preeclampsia. 
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